These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33358753)

  • 21. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation.
    Del Río-Gonzalez S; Aragon IM; Castillo E; Milla-España F; Galacho A; Machuca J; Lara MF; Herrera-Imbroda B
    Urology; 2017 Oct; 108():52-58. PubMed ID: 28687483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study.
    Scaldazza CV; Morosetti C; Giampieretti R; Lorenzetti R; Baroni M
    Int Braz J Urol; 2017; 43(1):121-126. PubMed ID: 28124534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-life data on long-term follow-up of patients successfully treated with percutaneous tibial nerve stimulation.
    Bianchi D; Iacovelli V; Parisi I; Petta F; Gaziev G; Topazio L; Bove P; Vespasiani G; Finazzi Agrò E
    Minerva Urol Nephrol; 2021 Apr; 73(2):260-264. PubMed ID: 31487975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous tibial nerve stimulation maintenance therapy for overactive bladder in women: long-term success rates and adherence.
    Jung CE; Menefee SA; Diwadkar GB
    Int Urogynecol J; 2021 Mar; 32(3):617-625. PubMed ID: 32572541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months.
    Vecchioli-Scaldazza C; Morosetti C
    Int Braz J Urol; 2018; 44(1):102-108. PubMed ID: 29064651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous Tibial Nerve Stimulation in Diabetic and Nondiabetic Women With Overactive Bladder Syndrome: A Retrospective Cohort Study.
    Zeno A; Handler SJ; Jakus-Waldman S; Yazdany T; Nguyen JN
    Female Pelvic Med Reconstr Surg; 2021 Nov; 27(11):686-690. PubMed ID: 34608031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 8 versus 12 weeks of percutaneous tibial nerve stimulation and response predictors for overactive bladder.
    Jung CE; Menefee SA; Diwadkar GB
    Int Urogynecol J; 2020 May; 31(5):905-914. PubMed ID: 31927598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S; Kabay S; Mestan E; Cetiner M; Ayas S; Sevim M; Ozden H; Karaman HO
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of idiopathic overactive bladder in women: Transcutaneous tibial nerve stimulation alone versus combined with pelvic floor muscle training].
    Baati R; Balhi S; Saadi A; Kraiem R; Kennou B; Ayed H; Chebil M
    Prog Urol; 2020 Dec; 30(17):1126-1133. PubMed ID: 32682849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
    Vecchioli-Scaldazza C; Morosetti C; Berouz A; Giannubilo W; Ferrara V
    Gynecol Obstet Invest; 2013; 75(4):230-4. PubMed ID: 23548260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system.
    Cornu JN; Hashim H; Van Der Aa F; De Nunzio C; Perez VG; Ferreira R; Elterman DS
    Can J Urol; 2023 Dec; 30(6):11756-11761. PubMed ID: 38104335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary Patterns of Third-line Treatments for Privately Insured Individuals With Overactive Bladder in the United States.
    Jiang J; Patil D; Traore EJ; Hammett J; Filson CP
    Urology; 2020 Aug; 142():87-93. PubMed ID: 32437771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V; Guzmán R; Naser M; Aguilera A; Narvaez S; Castro A; Swift S; Digesu GA
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis.
    Burton C; Sajja A; Latthe PM
    Neurourol Urodyn; 2012 Nov; 31(8):1206-16. PubMed ID: 22581511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review.
    Moossdorff-Steinhauser HF; Berghmans B
    Neurourol Urodyn; 2013 Mar; 32(3):206-14. PubMed ID: 22907807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM; Carrico DJ; MacDiarmid SA; Wooldridge LS; Khan AU; McCoy CE; Franco N; Bennett JB
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.